Ciccarelli, Nicoletta
 Distribuzione geografica
Continente #
EU - Europa 3.322
NA - Nord America 2.296
AS - Asia 772
AF - Africa 45
OC - Oceania 37
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.498
Nazione #
US - Stati Uniti d'America 2.234
DE - Germania 981
IT - Italia 663
SE - Svezia 393
FR - Francia 292
CN - Cina 278
PL - Polonia 273
SG - Singapore 208
GB - Regno Unito 184
UA - Ucraina 134
IE - Irlanda 115
IN - India 72
FI - Finlandia 67
ID - Indonesia 66
CA - Canada 43
ES - Italia 43
KR - Corea 39
AU - Australia 34
BE - Belgio 31
RU - Federazione Russa 31
PT - Portogallo 26
TR - Turchia 26
HK - Hong Kong 24
MX - Messico 17
NL - Olanda 17
BR - Brasile 16
CI - Costa d'Avorio 16
IR - Iran 14
AT - Austria 13
PH - Filippine 13
RO - Romania 12
GR - Grecia 10
CZ - Repubblica Ceca 9
CM - Camerun 8
JP - Giappone 8
ZA - Sudafrica 7
CH - Svizzera 6
NG - Nigeria 5
CO - Colombia 4
LT - Lituania 4
QA - Qatar 4
TW - Taiwan 4
UG - Uganda 4
EU - Europa 3
HU - Ungheria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
VN - Vietnam 3
AR - Argentina 2
BG - Bulgaria 2
DZ - Algeria 2
EG - Egitto 2
LB - Libano 2
MY - Malesia 2
SM - San Marino 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
PK - Pakistan 1
RS - Serbia 1
SR - Suriname 1
Totale 6.498
Città #
Chandler 472
Kraków 263
Singapore 165
Ashburn 156
Milan 148
Jacksonville 121
Dublin 112
New York 107
San Mateo 102
Ann Arbor 83
Cattolica 77
Nanjing 64
Jakarta 62
Nürnberg 58
Dearborn 54
Redwood City 52
Wilmington 47
Boston 44
Houston 39
Woodbridge 39
Redmond 34
Helsinki 32
Lawrence 28
Princeton 28
London 27
Rome 27
Brussels 25
Ottawa 24
Paris 24
Lancaster 23
Moscow 22
Izmir 21
Los Angeles 21
Seattle 21
Beijing 20
Marseille 19
Nanchang 19
Augusta 18
Mountain View 16
Chicago 15
Shenyang 15
Abidjan 14
Bremen 14
Catania 14
Fairfield 14
Norwalk 14
Leawood 13
Madrid 13
Changsha 12
Brescia 10
Cantù 10
Florence 10
Glasgow 10
Hong Kong 10
Kunming 10
Toronto 10
Vienna 10
Amsterdam 9
Boardman 9
Guangzhou 9
Hefei 9
Andover 8
Cambridge 8
Hebei 8
Hyderabad 8
Jiaxing 8
Melbourne 8
Munich 8
Turin 8
University Park 8
Falls Church 7
Kish 7
Pune 7
Warsaw 7
Bologna 6
Council Bluffs 6
Cusano Milanino 6
Davao City 6
Detroit 6
Fremont 6
Modena 6
Rochdale 6
Shanghai 6
Trieste 6
Washington 6
Albuquerque 5
Bari 5
Brisbane 5
Changchun 5
Hangzhou 5
Hobart 5
La Habra 5
Manchester 5
San Francisco 5
San Jose 5
Simi Valley 5
Atlanta 4
Bucharest 4
Busto Arsizio 4
Capua 4
Totale 3.205
Nome #
The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study 355
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 321
OXFORD COGNITIVE SCREEN (OCS) FEASIBILITY IN THE STROKE UNIT SETTING 253
Semantic memory in Object Use 241
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 225
Narrative discourse in logopenic variant of PPA: a multi-level approach 215
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 176
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease Select item 29019160 1. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease. 169
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 165
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 160
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 152
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 151
Primary progressive aphasia: linguistic patterns and clinical variants 146
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 140
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 140
AN ATTEMPT TO LOOK FOR DIFFERENCE BETWEEN DEGENERATIVE AND VASCULAR APHASIA: A DATA-DRIVEN CLUSTER ANALYSIS. 138
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 137
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 135
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 108
Unilateral Spatial Neglect in Degenerative Brain Pathology 108
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 108
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 106
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 106
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 105
Cognitive reserve and neuropsychological functioning in older HIV-infected people 102
POST-STROKE QUALITY OF LIFE AND COGNITIVE FUNCTIONING: A LONGITUDINAL STUDY 100
Effect of aging and human immunodeficiency virus infection on cognitive abilities 100
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 100
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. 97
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 97
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 96
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 95
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 91
Cognitive reserve: a multidimensional protective factor in Parkinson’s disease related cognitive impairment 88
Posterior AD-type pathology: cognitive subtypes emerging from a cluster analysis 87
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 86
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 83
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 82
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 79
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 78
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 77
The facial emotion recognition deficit in Parkinson's disease: Implications of a visual scanning strategy 73
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 73
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 71
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 71
Writing errors in primary progressive aphasia 65
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 64
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 61
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 61
Liver fibrosis is associated with cognitive impairment in people living with HIV 59
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 57
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 54
HIV 50
Degenerative and Vascular Fluent Aphasia: Looking for Differences 50
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 47
Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population 46
Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? 42
Cognitive reserve: a multidimensional protective factor in Parkinson's disease related cognitive impairment 27
Naming of grammatical classes in frontotemporal dementias: Linguistic and non linguistic factors contribute to noun-verb dissociation 23
Writing errors in primary progressive aphasia 17
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 16
Totale 6.625
Categoria #
all - tutte 22.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.633


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 0 0 0 0 64 40 52 59 46 72 35
2020/2021465 48 36 7 27 46 28 56 14 59 53 72 19
2021/2022679 51 40 21 90 32 30 30 111 23 51 67 133
2022/20231.439 167 205 77 213 90 153 77 136 179 37 74 31
2023/2024939 43 172 38 60 59 194 64 52 41 46 96 74
2024/2025566 28 53 195 78 161 51 0 0 0 0 0 0
Totale 6.625